The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Rural communities and health professional shortage areas (HPSA) and access to immune effector cellular therapy and lymphoma/myeloma clinical trials.
 
Nausheen Ahmed
Consulting or Advisory Role - Bristol-Myers Squibb
 
William Wesson
No Relationships to Disclose
 
Dinesh Pal Mudaranthakam
No Relationships to Disclose
 
Muhammad Umair Mushtaq
No Relationships to Disclose
 
Al-Ola A. Abdallah
No Relationships to Disclose
 
Forat Umair Lutfi
No Relationships to Disclose
 
Joaquina Celebre Baranda
Stock and Other Ownership Interests - Aprea Therapeutics; Forty Seven; Hylapharm; Merus NV; Moderna Therapeutics; MorphoSys; Zymeworks
Consulting or Advisory Role - Sanofi (Inst)
Research Funding - Astellas Pharma (Inst); Exelixis (Inst); Incyte (Inst); Lilly (Inst); Nektar (Inst); Pfizer (Inst); Regeneron (Inst); Sanofi (Inst); Tolero Pharmaceuticals (Inst); Xencor (Inst)
 
Sunil H. Abhyankar
Stock and Other Ownership Interests - Johnson & Johnson; Lilly O.; Merck; Pfizer
Honoraria - Incyte; Therakos
Speakers' Bureau - Incyte; Therakos
Travel, Accommodations, Expenses - Incyte; Therakos
 
Joseph McGuirk
Honoraria - AlloVir; Kite, a Gilead company; Magenta Therapeutics; Nektar; Sana Biotechnology
Consulting or Advisory Role - Allovir; crispr therapeutics; EcoR1 Capital; Juno Therapeutics; Kite, a Gilead company; Magenta Therapeutics
Speakers' Bureau - Kite/Gilead
Research Funding - AlloVir (Inst); Astellas Pharma (Inst); Bellicum Pharmaceuticals (Inst); Fresenius Biotech (Inst); Gamida Cell (Inst); Kite, a Gilead company (Inst); Novartis (Inst); Novartis (Inst); Pluristem Therapeutics (Inst)
Travel, Accommodations, Expenses - Kite, a Gilead company; SITC/ACCC; Syncopation Life Sciences
 
Marc Hoffmann
No Relationships to Disclose